- $9.68bn
- $8.81bn
- $570.40m
- 100
- 22
- 83
- 78
Annual balance sheet for Doximity, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 143 | 798 | 841 | 763 | 916 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 50.3 | 81.1 | 112 | 107 | 136 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 209 | 904 | 975 | 913 | 1,089 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 8.94 | 9.57 | 25.1 | 24.6 | 22.5 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 252 | 991 | 1,137 | 1,079 | 1,264 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 102 | 111 | 140 | 147 | 156 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 104 | 113 | 171 | 178 | 182 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 148 | 879 | 966 | 901 | 1,083 |
| Total Liabilities & Shareholders' Equity | 252 | 991 | 1,137 | 1,079 | 1,264 |
| Total Common Shares Outstanding |